Genmab A/S (GMAB)
34.74
+0.20
(+0.59%)
USD |
NASDAQ |
Sep 18, 16:00
34.71
-0.03
(-0.09%)
Pre-Market: 08:51
Genmab Total Long Term Debt (Quarterly) : 4.979B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.979B |
| March 31, 2026 | 5.076B |
| December 31, 2025 | 5.153B |
| September 30, 2025 | 142.00M |
| June 30, 2025 | 148.00M |
| March 31, 2025 | 143.00M |
| December 31, 2024 | 142.88M |
| September 30, 2024 | 147.77M |
| June 30, 2024 | 146.45M |
| March 31, 2024 | 146.24M |
| December 31, 2023 | 114.10M |
| September 30, 2023 | 112.59M |
| June 30, 2023 | 117.66M |
| March 31, 2023 | 120.91M |
| December 31, 2022 | 85.68M |
| September 30, 2022 | 82.87M |
| June 30, 2022 | 89.13M |
| March 31, 2022 | 62.23M |
| December 31, 2021 | 64.98M |
| September 30, 2021 | 68.11M |
| June 30, 2021 | 70.65M |
| March 31, 2021 | 59.74M |
| December 31, 2020 | 52.44M |
| September 30, 2020 | 53.09M |
| June 30, 2020 | 53.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.59M |
| December 31, 2019 | 27.19M |
| September 30, 2019 | 27.54M |
| June 30, 2019 | 29.61M |
| March 31, 2019 | 30.00M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.009M |
| December 31, 2015 | 0.0172M |
| September 30, 2015 | 0.0266M |
| June 30, 2015 | 0.0354M |
| March 31, 2015 | 0.0426M |
| December 31, 2014 | 0.0577M |
| September 30, 2014 | 0.0704M |
| June 30, 2014 | 0.087M |
| March 31, 2014 | 0.0987M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| AbbVie, Inc. | 70.82B |
| Ascendis Pharma A/S | 439.76M |
| Zealand Pharma A/S | 62.86M |
| Bavarian Nordic A/S | 19.76M |
| Evaxion AS | 7.105M |